Summit Therapeutics
SMMT
SMMT
52 hedge funds and large institutions have $11.7M invested in Summit Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Holders
52
Holding in Top 10
–
Calls
$33K
Puts
–
Top Buyers
| 1 | +$380K | |
| 2 | +$316K | |
| 3 | +$40.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.2K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$15.5K |
Top Sellers
| 1 | -$582K | |
| 2 | -$115K | |
| 3 | -$100K | |
| 4 |
BlackRock
New York
|
-$87.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$83.4K |